ANDREW MROWIEC: Open Payments
NPI 1780668640 · ABERDEEN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,620 in 86 payments from 15 companies in 2025. Trend: 2023 $2,371 · 2024 $1,957 · 2025 $1,620
Food & beverage: $1,620
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $265 |
| Amgen Inc. | 19 | $241 |
| AstraZeneca Pharmaceuticals LP | 9 | $188 |
| ABBVIE INC. | 11 | $171 |
| PFIZER INC. | 11 | $167 |
| Lilly USA, LLC | 7 | $137 |
| GlaxoSmithKline, LLC. | 6 | $120 |
| INTUITIVE SURGICAL, INC. | 1 | $77 |
| Exact Sciences Corporation | 3 | $67 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
Products named: MOUNJARO, FARXIGA, TRELEGY ELLIPTA, EVENITY, OTEZLA, NURTEC ODT, Wegovy, Ozempic.
Industry payments across MD — which companies pay providers there.
